| Literature DB >> 34947534 |
Dina Farrakhova1, Igor Romanishkin1, Yuliya Maklygina1, Lina Bezdetnaya2,3, Victor Loschenov1,4.
Abstract
Spectroscopic approach with fluorescence time resolution allows one to determine the state of a brain tumor and its microenvironment via changes in the fluorescent dye's fluorescence lifetime. Indocyanine green (ICG) is an acknowledged infra-red fluorescent dye that self-assembles into stable aggregate forms (ICG NPs). ICG NPs aggregates have a tendency to accumulate in the tumor with a maximum accumulation at 24 h after systemic administration, enabling extended intraoperative diagnostic. Fluorescence lifetime analysis of ICG and ICG NPs demonstrates different values for ICG monomers and H-aggregates, indicating promising suitability for fluorescent diagnostics of brain tumors due to their affinity to tumor cells and stability in biological tissue.Entities:
Keywords: H-aggregates; brain cancer; fluorescent diagnosis; fluorescent dyes; fluorescent lifetime; glioma C6; indocyanine green; near-infrared range
Year: 2021 PMID: 34947534 PMCID: PMC8709123 DOI: 10.3390/nano11123185
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1(a) Fluorescence spectra of ICG molecular solution in tumor xenografts at different times (λex = 633 nm). The data obtained from the study of normal skin samples at all time points fluctuate in the range between two spectral curves (pink color); (b) fluorescence spectra of ICG molecular solution in excretory organs 5 min after intravenous administration (λex = 633 nm); (c) integral dependence of the spectral curve of ICG molecular solution in tumor xenografts 5 min after intravenous administration (λex = 633 nm).
Figure 2(a) Fluorescence spectra of ICG NPs colloidal solution in tumor xenografts at different times (λex = 633 nm); (b) fluorescence spectra of ICG NPs colloidal solution in excretory organs 24 h after intravenous administration (λex = 633 nm); (c) integral dependence of the spectral curve of ICG NPs colloidal solution in tumor xenografts under 24 h after intravenous administration (λex = 633 nm).
Figure 3(a) Fluorescence spectra of fluorescence of ICG and ICG NPs accumulated in tumor xenograft; (b) profiles of fluorescence spectra of ICG and ICG NPs accumulated in tumor xenograft.
Fluorescence lifetime of ICG in monomeric and aggregate forms in tumor and healthy tissue.
| Sample | Fluorescence Lifetime τ, ns | Amplitude of Fluorescence Lifetime, % |
|---|---|---|
| ICG monomers in tumor | 0.55 ± 0.09 | 21% |
| 0.82 ± 0.03 | 79% | |
| ICG monomers in norma | 0.37 ± 0.09 | 64% |
| 0.75 ± 0.05 | 36% | |
| ICG H-aggregates in tumor | 0.28 ± 0.04 | 83% |
| 1.10 ± 0.09 | 17% | |
| ICG H-aggregates in norma | 0.27 ± 0.08 | 82% |
| 1.21 ± 0.11 | 18% | |
| ICG NPs H-aggregates in tumor | 0.26 ± 0.03 | 91% |
| 1.34 ± 0.07 | 9% | |
| ICG NPs H-aggregates in norma | 0.20 ± 0.04 | 97% |
| 1.00 ± 0.11 | 3% |